Key terms

About URGN

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest URGN news

Apr 18 6:15am ET Buy Rating Affirmed for Urogen Pharma Amid Promising Clinical Data and Strategic Conference Presentations by TipRanks Apr 15 8:07am ET UroGen Pharma announces FDA acceptance of UGM-103 IND by TipRanks Apr 09 7:40am ET Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Omeros (OMER) and Urogen Pharma (URGN) by TipRanks Apr 04 6:25am ET Urogen Pharma’s Strategic Defense and Pipeline Progress Bolster Buy Rating by TipRanks Apr 03 8:02am ET UroGen Pharma files patent infringement action against Teva Pharmaceuticals by TipRanks Mar 18 6:30am ET Analysts Offer Insights on Healthcare Companies: Aslan Pharmaceuticals (ASLN), Urogen Pharma (URGN) and Legend Biotech (LEGN) by TipRanks Mar 15 7:52am ET UroGen Pharma price target lowered to $34 from $35 at Oppenheimer by TipRanks Mar 14 3:40pm ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Urogen Pharma (URGN) and Cullinan Management (CGEM) by TipRanks Mar 14 1:05pm ET TD Cowen Sticks to Their Buy Rating for Urogen Pharma (URGN) by TipRanks Mar 01 7:12am ET Teva Challenges UroGen Pharma’s Jelmyto Patent Rights by TipRanks Feb 08 4:47am ET UroGen Pharma Shares Insights at Guggenheim Healthcare Talks by TipRanks Jan 24 8:34am ET UroGen Pharma price target raised to $35 from $32 at Oppenheimer by TipRanks Jan 24 8:15am ET UroGen initiates submission of rolling NDA to FDA for UGN-102 by TipRanks Jan 24 8:11am ET Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG) and Urogen Pharma (URGN) by TipRanks Jan 22 2:40pm ET Analysts Offer Insights on Healthcare Companies: SurModics (SRDX), Urogen Pharma (URGN) and Blueprint Medicines (BPMC) by TipRanks

No recent press releases are available for URGN

URGN Financials

1-year income & revenue

Key terms

URGN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

URGN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

A bubble tea store operated by Sichuan Baicha Baidao in Shanghai, China, on April 23, 2024.
Raul Ariano/Bloomberg/Getty Images
Is the tea bubble bursting? ChaPanda shares plunge in Hong Kong IPO
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Can markets make a comeback? That depends on tech earnings
People walk past the New York Stock Exchange Thursday, March. 21, 2024.
Yuki Iwamura/AP
Investors are fearful. They shouldn’t be
People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally